Behavior Genetics

, Volume 48, Issue 6, pp 440–450 | Cite as

Effects of Repeated Treatment with Midazolam in SHR and SLA16 Rat Strains in the Triple Test

  • Lucía Raily Acuña
  • Renata Cristina Nunes Marchette
  • Natalli Granzotto
  • Paula Gomes Dias
  • Maria Elisa Corvino
  • Fernando Gabriel Mazur
  • Fernanda Junques Corrêa
  • Geison Souza IzídioEmail author
Original Research


We exposed male and female rats of SHR (Spontaneously Hypertensive Rats) and SLA16 (SHR.LEW-Anxrr16) strains, in a non-drugged state, for five consecutive days to the Triple Test (experiment 1); or after repeated treatment with midazolam (MDZ), for four consecutive days. The fifth day was performed without treatment (experiment 2). The first experiment showed that males did not avoid and females increased the exploration of the open arms over the days. In experiment 2, SLA16 from both sexes approached more the open arms than SHR rats. The MDZ anxiolytic-like effect was sustained in both strains and sexes over the days. On the fifth day, SLA16 still approached more the open arms than SHR rats. Data suggest an absence of repeated-trial tolerance to MDZ anxiolytic-like effects. Testing the SHR and SLA16 strains, especially females, could be necessary for the future search for the genes and molecular pathways underlying anxiety/emotionality.


Midazolam Anxiety Emotionality Anxiolytic drugs Rats 



F. J. Correa and R. C. N. Marchette were recipients of fellowships from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). L. R. Acuña; N. GranzottoF. G. Mazur and E. Corvino were recipients of fellowships from Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). The authors also thank R. A. N. Pértile and T. M. Alves for their technical assistance.


This work was supported by Edital MCTI/CNPq 14/2013.

Compliance with ethical standards

Conflict of interest

Lucía Raily Acuña, Renata Cristina Nunes Marchette, Natalli Granzotto, Paula Gomes Dias, Maria Elisa Corvino, Fernando Gabriel Mazur, Fernanda Junques Corrêa and Geison Souza Izídio declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were by following the ethical standards of the institution or practice at which the studies were conducted and respected the guidelines of the local committee for Animal Care in Research (CEUA/UFSC) with the valid permission PP00903.

Supplementary material

10519_2018_9922_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 15 KB)
10519_2018_9922_MOESM2_ESM.docx (20 kb)
Supplementary material 2 (DOCX 20 KB)
10519_2018_9922_MOESM3_ESM.docx (21 kb)
Supplementary material 3 (DOCX 20 KB)


  1. Adamec R, Head D, Blundell J, Burton P, Berton O (2006) Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience. Physiol Behav 2:12–29CrossRefGoogle Scholar
  2. Albrechet-Souza L, Borelli KG, Brandao ML (2008) Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. J Neurosci Methods 169:109–118CrossRefGoogle Scholar
  3. Andreatini R, Vital M, Santos GL (2003) The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus maze. Eur Neuropsychopharmacol 13(Suppl. 4):S378–S379CrossRefGoogle Scholar
  4. Anselmi M, Correa FJ, Santos JR, Silva AF, Cunha JA, Leão AH, Campêlo CL, Ribeiro AM, Silva RH, Izídio GS (2016) Genetic evidence for chromosome 4 loci influencing learning and memory. Neurobiol Learn Mem 131:182–191CrossRefGoogle Scholar
  5. Becker JB, Prendergast BJ, Liang JW (2016) Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ 26:7–34Google Scholar
  6. Beery AK, Zucker I (2011) Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35:565–572CrossRefGoogle Scholar
  7. Bertoglio LJ, Carobrez AP (2002a) Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus maze. Pharmacol Biochem Behav 72:449–455CrossRefGoogle Scholar
  8. Bertoglio LJ, Carobrez AP (2002b) Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73(4):963–969CrossRefGoogle Scholar
  9. Bertoglio LJ, Carobrez AP (2003) Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats. Psychopharmacology 170:335–342CrossRefGoogle Scholar
  10. Bertoglio LJ, Carobrez AP (2004) Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 15(1):45–54CrossRefGoogle Scholar
  11. Bertoglio LJ, Joca SR, Guimaraes FS (2006) Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 175:183–188CrossRefGoogle Scholar
  12. Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205CrossRefGoogle Scholar
  13. Carvalho MC, Moreira CM, Zanoveli JM, Brandão ML (2012) Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze. J Psychopharmacol 26(4):543–554CrossRefGoogle Scholar
  14. Clayton JA, Collins FS (2014) Policy: NIH to balance sex in cell and animal studies. Nature 509:282–283CrossRefGoogle Scholar
  15. Cruz-Morales SE, Santos NR, Brandão ML (2002) One trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behavior 72:973–978CrossRefGoogle Scholar
  16. Dal-Cól ML, Pereira LO, Rosa VP, Calixto AV, Carobrez AP, Faria MS (2003) Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol Biochem Behav 74(2):395–400CrossRefGoogle Scholar
  17. Davids E, Zhang K, Tarazi FI, Baldessarini RJ (2003) Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 2003 42(1):1–21CrossRefGoogle Scholar
  18. de Araújo Godinho MA, Meneghini L, Lucinda AM, Borges FR, Sakae DY, Marino Neto J, Paschoalini MA, De Lima TC, Faria MS (2007) An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine. Behav Brain Res 4 180(1):86–94CrossRefGoogle Scholar
  19. De Medeiros GF, Pereira E, Granzotto N, Ramos A (2013) Low-anxiety rat phenotypes can be further reduced through genetic intervention. PLoS ONE 8(12):e83666CrossRefGoogle Scholar
  20. De Medeiros GF, Corrêa FJ, Corvino ME, Izídio GS, Ramos A (2014) The long way from complex phenotypes to genes: the story of rat chromosome 4 and its behavioral effects. World J Neurosci 4:203–215CrossRefGoogle Scholar
  21. Díaz-Véliz G, Butrón S, Benavides MS, Dussaubat N, Mora S (2000) Gender, estrous cycle, ovariectomy, and ovarian hormones influence the effects of diazepam on avoidance conditioning in rats. Pharmacol Biochem Behav 66(4):887–892CrossRefGoogle Scholar
  22. File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281–282CrossRefGoogle Scholar
  23. File SE, Zangrossi H (1993) “One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110:240–244CrossRefGoogle Scholar
  24. File SE, Zangrossi H Jr, Viana M, Graeff FG (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111(4):491–494CrossRefGoogle Scholar
  25. File SE, Gonzalez LE, Gallant R (1998) Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19:397–405CrossRefGoogle Scholar
  26. File SE, Gonzalez LE, Gallant R (1999) Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21:312–320CrossRefGoogle Scholar
  27. Fraser LM, Brown RE, Hussin A, Fontana M, Whittaker A, O’Leary TP, Lederle L, Holmes A, Ramos A (2010) Measuring anxiety- and locomotion related behaviours in mice: a new way of using old models. Psychopharmacology 211:99–112CrossRefGoogle Scholar
  28. Frussa-Filho R, Barbosa-Junior H, Silva RH, Da Cunha C, Mello CF (1999) Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments. Psychopharmacology (Berl) 147:168–173CrossRefGoogle Scholar
  29. Gonzalez LE, File SE (1997) A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci 17:1505–1511CrossRefGoogle Scholar
  30. Handley SL, Mcblane JW (1993) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 29:129–138CrossRefGoogle Scholar
  31. Hussin AT, Fraser LM, Ramos A, Brown RE (2012) The effect of chlordiazepoxide on measures of activity and anxiety in Swiss–Webster mice in the triple test. Neuropharmacology 63:883–889CrossRefGoogle Scholar
  32. Izídio GS, Spricigo LJR, Ramos A (2005) Genetic differences in the elevated plus-maze persist after first exposure of inbred rats to the test apparatus. Behav Process 68:129–134CrossRefGoogle Scholar
  33. Izídio GS, Oliveira LC, Oliveira LFG, Pereira E, Wehrmeister TD, Ramos A (2011) The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption. Mamm Genome 22(5–6):329–340CrossRefGoogle Scholar
  34. Johnston AL, File SE (1991) Sex differences in animal tests of anxiety. Physiol Behav 49(2):245–250CrossRefGoogle Scholar
  35. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185PubMedGoogle Scholar
  36. Lovick TA (2008) GABA in the female brain-oestrous cycle-related changes in GABAergic function in the periaqueductal grey matter. Pharmacol Biochem Behav 90(1):43–50CrossRefGoogle Scholar
  37. Maguire J, Mody I (2009) Steroid hormone fluctuations and GABAAR plasticity. Psychoneuroendocrinology 34(1):S84–S90CrossRefGoogle Scholar
  38. Mccullough LD, de Vries GJ, Miller VM, Becker JB, Sandberg K, Mccarthy MM (2014) NIH initiative to balance sex of animals in preclinical studies. Biol Sex Differ 5:15CrossRefGoogle Scholar
  39. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167CrossRefGoogle Scholar
  40. Pereira JK, Vieira RJ, Konishi CT, Ribeiro RA, Frussa-Filho R (1999) The phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65(10):101–107CrossRefGoogle Scholar
  41. Pértile R, Corvino ME, Marchette RCN, Pavesi E, Cavalli J, Ramos A, Izídio GS (2017) The quinpirole hypolocomotive effects are strain and route of administration dependent in SHR and SLA16 isogenic rats. Behav Genet 47(5):552–563CrossRefGoogle Scholar
  42. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33CrossRefGoogle Scholar
  43. Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res (85): 57–69CrossRefGoogle Scholar
  44. Ramos A, Moisan MP, Chaouloff F, Mormède C, Mormède P (1999) Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Mol Psychiatry (4):453–462CrossRefGoogle Scholar
  45. Ramos A, Pereira E, Martins GC, Wehrmeister TD, Izidio GS (2008) Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 193(2):277–288CrossRefGoogle Scholar
  46. Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113(2):237–242CrossRefGoogle Scholar
  47. Rodgers RJ, Lee C, Sheperd JK (1992) Effects of diazepam on behavioural an antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102–110CrossRefGoogle Scholar
  48. Roy V, Chapillon P, Jeljeli M, Caston J, Belzung C (2009) Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest. Psychopharmacology 203(1):131–141CrossRefGoogle Scholar
  49. Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31–39CrossRefGoogle Scholar
  50. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239–1247CrossRefGoogle Scholar
  51. Schneider P, Ho YJ, Spanagel R, Pawlak CR (2011) A novel elevated plus-maze procedure to avoid the one-trial tolerance problem. Front Behav Neurosci 5:43CrossRefGoogle Scholar
  52. Stern CAJ, Carobrez AP, Bertoglio LJ (2008) Aversive learning as a mechanism for lack of repeated anxiolytic- like effect in the elevated plus-maze. Pharmacol Biochem Behav 90:545–550CrossRefGoogle Scholar
  53. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469CrossRefGoogle Scholar
  54. Tropp J, Markus EJ (2001) Sex differences in the dynamics of cue utilization and exploratory behavior. Behav Brain Res 119(2):143–154CrossRefGoogle Scholar
  55. Vendruscolo LF, Terenina-Rigaldie E, Raba F, Ramos A, Takahashi RN, Morméde P (2006) Evidence for a female-specific effect of a chromosome 4 locus on anxiety-related behaviors and ethanol drinking in rats. Genes Brain Behav 5(6):441–450CrossRefGoogle Scholar
  56. Voikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72(1–2):271–281CrossRefGoogle Scholar
  57. Wehrmeister TD, Izídio GS, Pereira E, Izídio G, Ramos A (2010) Absence of repeated-trial tolerance to the anxiolytic-like effects of chlordiazepoxide in the rat triple test. Pharmacol Biochem Behav 97(2):301–309CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Lucía Raily Acuña
    • 1
  • Renata Cristina Nunes Marchette
    • 1
    • 2
  • Natalli Granzotto
    • 1
    • 2
  • Paula Gomes Dias
    • 1
  • Maria Elisa Corvino
    • 1
  • Fernando Gabriel Mazur
    • 1
  • Fernanda Junques Corrêa
    • 1
    • 2
  • Geison Souza Izídio
    • 1
    Email author
  1. 1.Laboratório de Genética do Comportamento, Departamento de Biologia Celular, Embriologia e Genética, Centro de Ciências BiológicasUniversidade Federal de Santa CatarinaFlorianópolisBrazil
  2. 2.Department of PharmacologyFederal University of Santa CatarinaFlorianópolisBrazil

Personalised recommendations